Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,679.2 | 94.11 | 4,03,076.28 | 2,000.46 | 0.95 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,544.5 | 78.74 | 1,73,924.39 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,504.2 | 24.66 | 1,21,456.43 | 1,485.4 | 1.06 | 4,254.47 | 397.42 |
Dr Reddys Laboratories Ltd DRREDDY | 1,320.9 | 20.6 | 1,10,189.83 | 1,200.7 | 0.61 | 5,546.3 | 345.81 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,154.3 | 56.03 | 1,06,756.13 | 474 | 1.01 | 2,385 | 224.33 |
This FDA audit confirms compliance with regulatory standards, enhancing the credibility of Jubilant's operations in the United States.
Jubilant Pharmova Ltd has gained a total of 126% in the last one year, and almost 75% gain since the beginning of the year.
Here are some of the stocks that may see significant price movement today: Tata Motors, Reliance Industries, IREDA, etc.
Drug company Jubilant Pharmova Ltd will acquire an 80% stake in Pierre Fabre Laboratories' Research & Development Centre in Saint Julien, France.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.